2018 |
Al-Hiyali, M Saya; Ishak, A J; Harun, H; Ahmad, S A; Sulaiman, Wan W A Tinjauan dalam mengubah suai tingkah laku pengambilan makanan oleh rangsangan otak: Kes berat badan berlebihan Artikel Jurnal Kuantologi Neuro, 16 (12), hlm. 86-97, 2018, ISSN: 13035150, (dipetik oleh 2). Abstrak | Pautan | BibTeX | Tag: Amygdala, Anoksia, Artikel, Autisme, Gangguan pesta minum-minum makan, Berat badan, Berat badan, Rangsangan Kedalaman Otak, Depolarisasi, Pengambilan diet, Keinginan Dadah, Gangguan Makan, Arus elektrik, Elektroencephalogram, Elektroensefalografi, Penggunaan tenaga, Penggunaan tenaga, Tingkah Laku Makan, Pengambilan makanan, Pengimejan Resonans Magnetik Berfungsi, Jantina, Status kesihatan, Homeostasis, Manusia, Kelaparan, Gaya hidup, Potensi Mantap Membran Sel Saraf, Keseronokan Saraf, Neurofeedback, Neuromodulasi, Penilaian Pemakanan, Penilaian Hasil, Soal selidik, Rangsangan Magnetik Transkranial Berulang, Pemprosesan isyarat, Latihan, Rangsangan Arus Langsung Transkranial, Rangsangan Magnetik Transkranial, Berat badan kurang @artikel{Al-Hiyali201886, tajuk = {Tinjauan dalam mengubah suai tingkah laku pengambilan makanan oleh rangsangan otak: Kes berat badan berlebihan}, pengarang = {M I Al-Hiyali dan A J Ishak dan H Harun dan S A Ahmad dan W A Wan Sulaiman}, url = {https://www.scopus.com/inward/record.uri?eid = 2-s2.0-85062843670&doi = 10.14704% 2fnq.2018.16.12.1894&rakan kongsi = 40&md5 = 235f66cef05a144be23472641f70bd1d}, doi = {10.14704/nq.2018.16.12.1894}, terbitan = {13035150}, tahun = {2018}, tarikh = {2018-01-01}, jurnal = {Kuantologi Neuro}, isi padu = {16}, nombor = {12}, halaman = {86-97}, penerbit = {Penerbit Anka}, abstrak = {Obesiti dan berat badan berlebihan sering ditetapkan untuk disfungsi dalam tingkah laku pengambilan makanan. Kerana banyaknya kegemukan pada tahun lalu, terdapat permintaan untuk lebih banyak kajian yang bertujuan untuk mengubah tingkah laku pengambilan makanan. Selama beberapa dekad yang lalu, banyak kajian telah dilakukan untuk mengubah pengambilan makanan melalui latihan otak atau rangsangan. Ulasan ini untuk kajian neurosains dalam mengubah tingkah laku pengambilan makanan, ia melibatkan tiga bahagian; Bahagian pertama menjelaskan peranan aktiviti otak dalam peraturan pengambilan makanan, idea umum mengenai alat bioperubatan dalam tingkah laku pengambilan makanan dibincangkan di bahagian kedua dan bahagian ketiga yang difokuskan pada sistem rangsangan otak. Akhirnya, makalah ini disimpulkan dengan perkara utama yang perlu diambil kira semasa merancang kajian eksperimental untuk mengubah tingkah laku pengambilan makanan oleh rangsangan otak mengikut cadangan dan cabaran kajian sebelumnya. © 2018, Penerbit Anka. Hak cipta terpelihara.}, nota = {dipetik oleh 2}, kata kunci = {Amygdala, Anoksia, Artikel, Autisme, Gangguan pesta minum-minum makan, Berat badan, Berat badan, Rangsangan Kedalaman Otak, Depolarisasi, Pengambilan diet, Keinginan Dadah, Gangguan Makan, Arus elektrik, Elektroencephalogram, Elektroensefalografi, Penggunaan tenaga, Penggunaan tenaga, Tingkah Laku Makan, Pengambilan makanan, Pengimejan Resonans Magnetik Berfungsi, Jantina, Status kesihatan, Homeostasis, Manusia, Kelaparan, Gaya hidup, Potensi Mantap Membran Sel Saraf, Keseronokan Saraf, Neurofeedback, Neuromodulasi, Penilaian Pemakanan, Penilaian Hasil, Soal selidik, Rangsangan Magnetik Transkranial Berulang, Pemprosesan isyarat, Latihan, Rangsangan Arus Langsung Transkranial, Rangsangan Magnetik Transkranial, Berat badan kurang}, pubstate = {diterbitkan}, tppubtype = {artikel} } Obesiti dan berat badan berlebihan sering ditetapkan untuk disfungsi dalam tingkah laku pengambilan makanan. Kerana banyaknya kegemukan pada tahun lalu, terdapat permintaan untuk lebih banyak kajian yang bertujuan untuk mengubah tingkah laku pengambilan makanan. Selama beberapa dekad yang lalu, banyak kajian telah dilakukan untuk mengubah pengambilan makanan melalui latihan otak atau rangsangan. Ulasan ini untuk kajian neurosains dalam mengubah tingkah laku pengambilan makanan, ia melibatkan tiga bahagian; Bahagian pertama menjelaskan peranan aktiviti otak dalam peraturan pengambilan makanan, idea umum mengenai alat bioperubatan dalam tingkah laku pengambilan makanan dibincangkan di bahagian kedua dan bahagian ketiga yang difokuskan pada sistem rangsangan otak. Akhirnya, makalah ini disimpulkan dengan perkara utama yang perlu diambil kira semasa merancang kajian eksperimental untuk mengubah tingkah laku pengambilan makanan oleh rangsangan otak mengikut cadangan dan cabaran kajian sebelumnya. © 2018, Penerbit Anka. Hak cipta terpelihara. |
2016 |
Tan, M L; Ho, BUKAN PERKATAAN; Teh, K H Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders Artikel Jurnal Pangkalan Data Cochrane dari Ulasan Sistematik, 2016 (9), 2016, ISSN: 1469493X, (dipetik oleh 6). Abstrak | Pautan | BibTeX | Tag: Gangguan Defisit Perhatian, Autisme, Carnosine, Anak-anak, Diet Supplementation, Drug Effect, Gastrointestinal Symptom, Manusia, Gangguan Pembelajaran, Meta Analysis, Penilaian Hasil, Placebo, Polyunsaturated Fatty Acid, Jurnal Keutamaan, Percubaan Terkawal Rawak, Kaji semula, Kajian Sistematik @artikel{Tan2016, tajuk = {Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders}, pengarang = {M L Tan and J J Ho and K H Teh}, url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988922340&doi=10.1002%2f14651858.CD009398.pub3&rakan kongsi = 40&md5=3460f403b8829b4692a0b6f795f4a2a3}, doi = {10.1002/14651858.CD009398.pub3}, terbitan = {1469493X}, tahun = {2016}, tarikh = {2016-01-01}, jurnal = {Pangkalan Data Cochrane dari Ulasan Sistematik}, isi padu = {2016}, nombor = {9}, penerbit = {John Wiley and Sons Ltd}, abstrak = {Latar belakang: About 5% of school children have a specific learning disorder, defined as unexpected failure to acquire adequate abilities in reading, writing or mathematics that is not a result of reduced intellectual ability, inadequate teaching or social deprivation. Of these events, 80% are reading disorders. Polyunsaturated fatty acids (PUFAs), in particular, omega-3 and omega-6 fatty acids, which normally are abundant in the brain and in the retina, are important for learning. Some children with specific learning disorders have been found to be deficient in these PUFAs, and it is argued that supplementation of PUFAs may help these children improve their learning abilities. Objektif: 1. To assess effects on learning outcomes of supplementation of polyunsaturated fatty acids (PUFAs) for children with specific learning disorders.2. To determine whether adverse effects of supplementation of PUFAs are reported in these children. Search methods: In November 2015, we searched CENTRAL, Ovid MEDLINE, Embase, PsycINFO, 10 other databases and two trials registers. We also searched the reference lists of relevant articles. Selection criteria: Randomised controlled trials (RCTs) or quasi-RCTs comparing PUFAs with placebo or no treatment in children younger than 18 years with specific learning disabilities, as diagnosed in accordance with the fifth (or earlier) edition of theDiagnostic and Statistical Manual of Mental Disorders (DSM-5), or the 10th (or earlier) revision of the International Classification of Diseases (ICD-10) or equivalent criteria. We included children with coexisting developmental disorders such as attention deficit hyperactivity disorder (ADHD) or autism. Data collection and analysis: Two review authors (MLT and KHT) independently screened the titles and abstracts of articles identified by the search and eliminated all studies that did not meet the inclusion criteria. We contacted study authors to ask for missing information and clarification, when needed. We used the GRADE approach to assess the quality of evidence. Main results: Two small studies involving 116 kanak-kanak, mainly boys between 10 dan 18 years of age, met the inclusion criteria. One study was conducted in a school setting, the other at a specialised clinic. Both studies used three months of a combination of omega-3 and omega-6 supplements as the intervention compared with placebo. Although both studies had generally low risk of bias, we judged the risk of reporting bias as unclear in one study, and as high in the other study. Sebagai tambahan, one of the studies was funded by industry and reported active company involvement in the study. None of the studies reported data on the primary outcomes of reading, menulis, spelling and mathematics scores, as assessed by standardised tests. Evidence of low quality indicates that supplementation of PUFAs did not increase the risk of gastrointestinal disturbances (risk ratio 1.43, 95% confidence interval 0.25 ke 8.15; two studies, 116 kanak-kanak). Investigators reported no other adverse effects. Both studies reported attention deficit hyperactivity disorder (ADHD)-related behaviour outcomes. We were unable to combine the results in a meta-analysis because one study reported findings as a continuous outcome, and the other as a dichotomous outcome. No other secondary outcomes were reported. We excluded one study because it used a cointervention (carnosine), and five other studies because they did not provide a robust diagnosis of a specific learning disorder. We identified one ongoing study and found three studies awaiting classification. Authors' conclusions: Evidence is insufficient to permit any conclusions about the effect of PUFAs on the learning abilities of children with specific learning disorders. Well-designed RCTs with clearly defined populations of children with specific learning disorders who have been diagnosed by standardised diagnostic criteria are needed. © 2016 The Cochrane Collaboration.}, nota = {dipetik oleh 6}, kata kunci = {Gangguan Defisit Perhatian, Autisme, Carnosine, Anak-anak, Diet Supplementation, Drug Effect, Gastrointestinal Symptom, Manusia, Gangguan Pembelajaran, Meta Analysis, Penilaian Hasil, Placebo, Polyunsaturated Fatty Acid, Jurnal Keutamaan, Percubaan Terkawal Rawak, Kaji semula, Kajian Sistematik}, pubstate = {diterbitkan}, tppubtype = {artikel} } Latar belakang: About 5% of school children have a specific learning disorder, defined as unexpected failure to acquire adequate abilities in reading, writing or mathematics that is not a result of reduced intellectual ability, inadequate teaching or social deprivation. Of these events, 80% are reading disorders. Polyunsaturated fatty acids (PUFAs), in particular, omega-3 and omega-6 fatty acids, which normally are abundant in the brain and in the retina, are important for learning. Some children with specific learning disorders have been found to be deficient in these PUFAs, and it is argued that supplementation of PUFAs may help these children improve their learning abilities. Objektif: 1. To assess effects on learning outcomes of supplementation of polyunsaturated fatty acids (PUFAs) for children with specific learning disorders.2. To determine whether adverse effects of supplementation of PUFAs are reported in these children. Search methods: In November 2015, we searched CENTRAL, Ovid MEDLINE, Embase, PsycINFO, 10 other databases and two trials registers. We also searched the reference lists of relevant articles. Selection criteria: Randomised controlled trials (RCTs) or quasi-RCTs comparing PUFAs with placebo or no treatment in children younger than 18 years with specific learning disabilities, as diagnosed in accordance with the fifth (or earlier) edition of theDiagnostic and Statistical Manual of Mental Disorders (DSM-5), or the 10th (or earlier) revision of the International Classification of Diseases (ICD-10) or equivalent criteria. We included children with coexisting developmental disorders such as attention deficit hyperactivity disorder (ADHD) or autism. Data collection and analysis: Two review authors (MLT and KHT) independently screened the titles and abstracts of articles identified by the search and eliminated all studies that did not meet the inclusion criteria. We contacted study authors to ask for missing information and clarification, when needed. We used the GRADE approach to assess the quality of evidence. Main results: Two small studies involving 116 kanak-kanak, mainly boys between 10 dan 18 years of age, met the inclusion criteria. One study was conducted in a school setting, the other at a specialised clinic. Both studies used three months of a combination of omega-3 and omega-6 supplements as the intervention compared with placebo. Although both studies had generally low risk of bias, we judged the risk of reporting bias as unclear in one study, and as high in the other study. Sebagai tambahan, one of the studies was funded by industry and reported active company involvement in the study. None of the studies reported data on the primary outcomes of reading, menulis, spelling and mathematics scores, as assessed by standardised tests. Evidence of low quality indicates that supplementation of PUFAs did not increase the risk of gastrointestinal disturbances (risk ratio 1.43, 95% confidence interval 0.25 ke 8.15; two studies, 116 kanak-kanak). Investigators reported no other adverse effects. Both studies reported attention deficit hyperactivity disorder (ADHD)-related behaviour outcomes. We were unable to combine the results in a meta-analysis because one study reported findings as a continuous outcome, and the other as a dichotomous outcome. No other secondary outcomes were reported. We excluded one study because it used a cointervention (carnosine), and five other studies because they did not provide a robust diagnosis of a specific learning disorder. We identified one ongoing study and found three studies awaiting classification. Authors' conclusions: Evidence is insufficient to permit any conclusions about the effect of PUFAs on the learning abilities of children with specific learning disorders. Well-designed RCTs with clearly defined populations of children with specific learning disorders who have been diagnosed by standardised diagnostic criteria are needed. © 2016 The Cochrane Collaboration. |
2015 |
Alwi, N; Harun, D; Leonard, J H Clinical application of sensory integration therapy for children with autism Artikel Jurnal Egyptian Journal of Medical Human Genetics, 16 (4), hlm. 393-394, 2015, ISSN: 11108630, (dipetik oleh 1). Pautan | BibTeX | Tag: Autisme, Keterukan Penyakit, Groups by Age, Manusia, Surat, Motor Performance, Penilaian Hasil, Sensorimotor Integration, Terapi, Therapy Effect, Treatment Indication, Treatment Response @artikel{Alwi2015393, tajuk = {Clinical application of sensory integration therapy for children with autism}, pengarang = {N Alwi and D Harun and J H Leonard}, url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940898525&doi=10.1016%2fj.ejmhg.2015.05.009&rakan kongsi = 40&md5=5548f0db22520a480f09da9aaf4c872e}, doi = {10.1016/j.ejmhg.2015.05.009}, terbitan = {11108630}, tahun = {2015}, tarikh = {2015-01-01}, jurnal = {Egyptian Journal of Medical Human Genetics}, isi padu = {16}, nombor = {4}, halaman = {393-394}, penerbit = {Egyptian Society of Human Genetics}, nota = {dipetik oleh 1}, kata kunci = {Autisme, Keterukan Penyakit, Groups by Age, Manusia, Surat, Motor Performance, Penilaian Hasil, Sensorimotor Integration, Terapi, Therapy Effect, Treatment Indication, Treatment Response}, pubstate = {diterbitkan}, tppubtype = {artikel} } |
2010 |
Patel, V; Mungkin, M; Flisher, A J; Silva, Dari M J; Koschorke, M; Putera, M; Tempier, R; Ikan, M B; Sanchez, M; Campodonico, F D; Risiko, L; Gask, L; Wahlberg, H; Roca, M; Lecic-Tosevski, D; Soghoyan, A; Moussaoui, D; Baddoura, C; Adeyemi, J; Rataemane, S; Jalili, S A; Mohandas, E; Shinfuku, N; Freidin, J; Stagnaro, J C; Puig, Saya J; Kirkby, K; Musalek, M; Ismayilov, N; Rabbani, G; Harvey, S; Sabbe, B; Noya-Tapia, N; Burgic-Radmanovic, M; Hetem, L A; Vasconcellos, F; Maass, J; Miranda, C; Papaneophytou, N; Raboch, J; Fink-Jensen, A; Okasha, A; Korkeila, J; Guelphs, J D; Schneider, F; Ohene, S; Christodoulou, G; Askar, C R; Barrera, S K E Q; Mendoza, M; Kallivayalil, R A; Gudarzi, S S; Lafta, ENCIK; Bass, M; Kerani, M; Gibson, R; Yang mana, T; Nurmagambetova, S; Untuk, S -C; Kadyrova, T; Mikati, N; Bajraktarov, S; Yen, T H; Ayushjav, B; Stevovic, L Saya; Molina, J S S; Gureje, THE; Johannessen, J O; Hakim, H R; Al-Ashhab, B; Araszkiewicz, A; Prelipceanu, D; Krasnov, V; Bogdanov, A; Jasovic-Gasic, M; Ваврусова, L; Pregelj, P; Kebebasan, A F; Abdelrahman, A; Udomratn, P; Kaji semula, H; Gokaip, P; Kigozi, F N; Richardson, G Reducing the treatment gap for mental disorders: A WPA survey Artikel Jurnal World Psychiatry, 9 (3), hlm. 169-176, 2010, ISSN: 17238617, (dipetik oleh 127). Abstrak | Pautan | BibTeX | Tag: Anxiety Disorder, Artikel, Atomoxetine, Atypical Antipsychotic Agent, Autisme, Benzodiazepine, Bipolar Disorder, Perangsang Sistem Saraf Pusat, Cholinesterase Inhibitor, Cognitive Therapy, Community Mental Health Center, Conduct Disorder, Cost Effectiveness Analysis, Dementia, Kemurungan, Amalan Berasaskan Bukti, Keluarga, Family Therapy, Haloperidol, Penjagaan Kesihatan, Akses Penjagaan Kesihatan, Penyampaian Penjagaan Kesihatan, Kakitangan Penjagaan Kesihatan, Health Practitioner, Tinjauan Kesihatan, Help Seeking Behavior, Home Mental Health Care, Manusia, Hyperkinesia, Long Term Care, Lowest Income Group, Mental Deficiency, Mental Disease, Kesihatan mental, Mental Health Care, Perkhidmatan Kesihatan Mental, Nootropic Agent, Open Ended Questionnaire, Penilaian Hasil, Patient Compliance, Personality Disorder, Garis Panduan Amalan, Jurnal Keutamaan, Psychiatry, Psychoeducation, Psychotherapy, Skizofrenia, Serotonin Noradrenalin Reuptake Inhibitor, Perencat Serapan Serotonin, Substance Abuse, Terapi, Therapy Delay, Tricyclic Antidepressant Agent, World Health Organization @artikel{Patel2010169, tajuk = {Reducing the treatment gap for mental disorders: A WPA survey}, pengarang = {V Patel and M Maj and A J Flisher and M J De Silva and M Koschorke and M Prince and R Tempier and M B Riba and M Sanchez and F D Campodonico and L Risco and L Gask and H Wahlberg and M Roca and D Lecic-Tosevski and A Soghoyan and D Moussaoui and C Baddoura and J Adeyemi and S Rataemane and S A Jalili and E Mohandas and N Shinfuku and J Freidin and J C Stagnaro and I J Puig and K Kirkby and M Musalek and N Ismayilov and G Rabbani and S Harvey and B Sabbe and N Noya-Tapia and M Burgic-Radmanovic and L A Hetem and F Vasconcellos and J Maass and C Miranda and N Papaneophytou and J Raboch and A Fink-Jensen and A Okasha and J Korkeila and J D Guelfi and F Schneider and S Ohene and G Christodoulou and C R Soldatos and S K E Q Barrera and M Mendoza and R A Kallivayalil and S S Gudarzi and M R Lafta and M Bassi and M Clerici and R Gibson and T Kojima and S Nurmagambetova and S -C Cho and T Kadyrova and N Mikati and S Bajraktarov and T H Yen and B Ayushjav and L I Stevovic and J S S Molina and O Gureje and J O Johannessen and H R Chaudhry and B Al-Ashhab and A Araszkiewicz and D Prelipceanu and V Krasnov and A Bogdanov and M Jasovic-Gasic and L Vavrusova and P Pregelj and A F Liria and A Abdelrahman and P Udomratn and H Ulas and P Gokaip and F N Kigozi and G Richardson}, url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-79851492757&doi=10.1002%2fj.2051-5545.2010.tb00305.x&rakan kongsi = 40&md5=ebf47e1e84f22271aea10a73c93e9892}, doi = {10.1002/j.2051-5545.2010.tb00305.x}, terbitan = {17238617}, tahun = {2010}, tarikh = {2010-01-01}, jurnal = {World Psychiatry}, isi padu = {9}, nombor = {3}, halaman = {169-176}, penerbit = {Blackwell Publishing Ltd}, abstrak = {The treatment gap for people with mental disorders exceeds 50% in all countries of the world, approaching astonishingly high rates of 90% in the least resourced countries. We report the findings of the first systematic survey of leaders of psychiatry in nearly 60 countries on the strategies for reducing the treatment gap. We sought to elicit the views of these representatives on the roles of different human resources and health care settings in delivering care and on the importance of a range of strategies to increase the coverage of evidence-based treatments for priority mental disorders for each demographic stage (childhood, adolescence, adulthood and old age). Our findings clearly indicate three strategies for reducing the treatment gap: increasing the numbers of psychiatrists and other mental health professionals; increasing the involvement of a range of appropriately trained non-specialist providers; and the active involvement of people affected by mental disorders. This is true for both high income and low/middle income countries, though relatively of more importance in the latter. We view this survey as a critically important first step in ascertaining the position of psychiatrists, one of the most influential stakeholder communities in global mental health, in addressing the global challenge of scaling up mental health services to reduce the treatment gap.}, nota = {dipetik oleh 127}, kata kunci = {Anxiety Disorder, Artikel, Atomoxetine, Atypical Antipsychotic Agent, Autisme, Benzodiazepine, Bipolar Disorder, Perangsang Sistem Saraf Pusat, Cholinesterase Inhibitor, Cognitive Therapy, Community Mental Health Center, Conduct Disorder, Cost Effectiveness Analysis, Dementia, Kemurungan, Amalan Berasaskan Bukti, Keluarga, Family Therapy, Haloperidol, Penjagaan Kesihatan, Akses Penjagaan Kesihatan, Penyampaian Penjagaan Kesihatan, Kakitangan Penjagaan Kesihatan, Health Practitioner, Tinjauan Kesihatan, Help Seeking Behavior, Home Mental Health Care, Manusia, Hyperkinesia, Long Term Care, Lowest Income Group, Mental Deficiency, Mental Disease, Kesihatan mental, Mental Health Care, Perkhidmatan Kesihatan Mental, Nootropic Agent, Open Ended Questionnaire, Penilaian Hasil, Patient Compliance, Personality Disorder, Garis Panduan Amalan, Jurnal Keutamaan, Psychiatry, Psychoeducation, Psychotherapy, Skizofrenia, Serotonin Noradrenalin Reuptake Inhibitor, Perencat Serapan Serotonin, Substance Abuse, Terapi, Therapy Delay, Tricyclic Antidepressant Agent, World Health Organization}, pubstate = {diterbitkan}, tppubtype = {artikel} } The treatment gap for people with mental disorders exceeds 50% in all countries of the world, approaching astonishingly high rates of 90% in the least resourced countries. We report the findings of the first systematic survey of leaders of psychiatry in nearly 60 countries on the strategies for reducing the treatment gap. We sought to elicit the views of these representatives on the roles of different human resources and health care settings in delivering care and on the importance of a range of strategies to increase the coverage of evidence-based treatments for priority mental disorders for each demographic stage (childhood, adolescence, adulthood and old age). Our findings clearly indicate three strategies for reducing the treatment gap: increasing the numbers of psychiatrists and other mental health professionals; increasing the involvement of a range of appropriately trained non-specialist providers; and the active involvement of people affected by mental disorders. This is true for both high income and low/middle income countries, though relatively of more importance in the latter. We view this survey as a critically important first step in ascertaining the position of psychiatrists, one of the most influential stakeholder communities in global mental health, in addressing the global challenge of scaling up mental health services to reduce the treatment gap. |
2018 |
Tinjauan dalam mengubah suai tingkah laku pengambilan makanan oleh rangsangan otak: Kes berat badan berlebihan Artikel Jurnal Kuantologi Neuro, 16 (12), hlm. 86-97, 2018, ISSN: 13035150, (dipetik oleh 2). |
2016 |
Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders Artikel Jurnal Pangkalan Data Cochrane dari Ulasan Sistematik, 2016 (9), 2016, ISSN: 1469493X, (dipetik oleh 6). |
2015 |
Clinical application of sensory integration therapy for children with autism Artikel Jurnal Egyptian Journal of Medical Human Genetics, 16 (4), hlm. 393-394, 2015, ISSN: 11108630, (dipetik oleh 1). |
2010 |
Reducing the treatment gap for mental disorders: A WPA survey Artikel Jurnal World Psychiatry, 9 (3), hlm. 169-176, 2010, ISSN: 17238617, (dipetik oleh 127). |